milnacipran hydrochloride

URI: https://gptkb.org/entity/milnacipran_hydrochloride
GPTKB entity
Statements (33)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkb:serotonin–norepinephrine_reuptake_inhibitor
gptkbp:approvedBy gptkb:Europe
gptkb:Japan
gptkb:United_States
gptkbp:ATCCode N06AX17
gptkbp:brand gptkb:Savella
gptkb:Ixel
Toledomin
gptkbp:CASNumber 910482-45-6
gptkbp:chemicalFormula C15H22N2O.ClH
gptkbp:contraindication uncontrolled narrow-angle glaucoma
concurrent MAOI use
gptkbp:developedBy Pierre Fabre Medicament
gptkbp:drugClass gptkb:antidepressant
gptkbp:eliminationHalfLife 8 hours
gptkbp:excretion urine
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits reuptake of serotonin and norepinephrine
gptkbp:metabolism liver
gptkbp:molecularWeight 282.81 g/mol
gptkbp:pregnancyCategory C (US)
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
constipation
headache
insomnia
increased sweating
gptkbp:usedFor gptkb:major_depressive_disorder
fibromyalgia
gptkbp:bfsParent gptkb:Savella
gptkbp:bfsLayer 8
https://www.w3.org/2000/01/rdf-schema#label milnacipran hydrochloride